Similarly, PRKDC upregulation has been reported to induce a G2/M transition in MCF-7 breast cancer cells [96] and the inhibition of its protein product has been reported to induce a G2/M arrest in primary NSCLC cells [97]. This evidence concerns the gene PRKDC and breast carcinoma.